GLORIA - Comparing the effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis

Academic head of project management: Zoltán Szekanecz

  • Title of project: GLORIA - A további alacsony dózisú glükokortikoid hatékonyságának és biztonságosságának összehasonlítása a reumatoid artritiszben szenvedő idős betegek kezelési stratégiáiban
  • Type of grant: H2020
  • Description: The objective of the project is to prove that the complementation of the current therapy treating rheumatism with chronic low-dose glucocorticoids (GC) is extremely cost effective and safe in the case of elderly patients with rheumatoid arthritis.
  • The duration of the project: September 1, 2015 – August 31, 2020
  • Actual total cost: 203.095 (EUR)
  • Type of research: Experimental
  • Consortium details:
    • Lead applicant: Stichting VU-VUmc
    • Consortium partner:
      • UNIVERSITA DEGLI STRUDI DI GENOVA (UNIGE)
      • Stichting Tools
      • BLUEPHARMA - INDUSTRIA FARMACEUTICASA (BLUEPHARMA)
      • ASSIGN BENELUX DEVELOPMENT BV (ABD)
      • CLINQUEST SERVICES BV (Clinquest Services B.V.)
      • QOLPAC BV (QOLPAC BV)
      • UNIVERSITATEA DE MEDICINA SI FARMACIE'CAROL DAVILA' DIN BUCURESTI
      • NARODNY USTAV REUMATICKYCH CHOROB-NURCH NIRD NATIONAL INSTITUTE OF RHEUMATIC DISEASES (NURCH NIRD)
      • CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA E.P.E (CHUC, E.P.E)
      • Charité - Universitätsmedizin Berlin
      • Debreceni Egyetem
Last update: 2021. 08. 16. 11:01